Hypertension in pregnancy.Cardiol Clin. 2012 Aug; 30(3):407-23.CC
Abstract
Hypertension in pregnancy is diagnosed on systolic blood pressure greater than or equal to 140 mm Hg and/or diastolic greater than or equal to 90 mm Hg. The classification systems separate chronic and gestational hypertension from preeclampsia. Significant uncertainty regarding optimal management is reflected in the differing major international society recommendations. Blood pressure treatment is designed to minimize maternal end-organ damage. Methyldopa, labetalol, hydralazine, and nifedipine are oral options; angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists are contraindicated. Women with preeclampsia should be closely monitored and receive intravenous magnesium sulfate.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
22813366
Citation
Vest, Amanda R., and Leslie S. Cho. "Hypertension in Pregnancy." Cardiology Clinics, vol. 30, no. 3, 2012, pp. 407-23.
Vest AR, Cho LS. Hypertension in pregnancy. Cardiol Clin. 2012;30(3):407-23.
Vest, A. R., & Cho, L. S. (2012). Hypertension in pregnancy. Cardiology Clinics, 30(3), 407-23. https://doi.org/10.1016/j.ccl.2012.04.005
Vest AR, Cho LS. Hypertension in Pregnancy. Cardiol Clin. 2012;30(3):407-23. PubMed PMID: 22813366.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Hypertension in pregnancy.
AU - Vest,Amanda R,
AU - Cho,Leslie S,
Y1 - 2012/06/12/
PY - 2012/7/21/entrez
PY - 2012/7/21/pubmed
PY - 2012/10/25/medline
SP - 407
EP - 23
JF - Cardiology clinics
JO - Cardiol Clin
VL - 30
IS - 3
N2 - Hypertension in pregnancy is diagnosed on systolic blood pressure greater than or equal to 140 mm Hg and/or diastolic greater than or equal to 90 mm Hg. The classification systems separate chronic and gestational hypertension from preeclampsia. Significant uncertainty regarding optimal management is reflected in the differing major international society recommendations. Blood pressure treatment is designed to minimize maternal end-organ damage. Methyldopa, labetalol, hydralazine, and nifedipine are oral options; angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists are contraindicated. Women with preeclampsia should be closely monitored and receive intravenous magnesium sulfate.
SN - 1558-2264
UR - https://www.unboundmedicine.com/medline/citation/22813366/Hypertension_in_pregnancy_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0733-8651(12)00056-2
DB - PRIME
DP - Unbound Medicine
ER -